304 related articles for article (PubMed ID: 35278352)
1. The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.
Wang H; Rong X; Zhao G; Zhou Y; Xiao Y; Ma D; Jin X; Wu Y; Yan Y; Yang H; Zhou Y; Qian M; Niu C; Hu X; Li DQ; Liu Q; Wen Y; Jiang YZ; Zhao C; Shao ZM
Cell Metab; 2022 Apr; 34(4):581-594.e8. PubMed ID: 35278352
[TBL] [Abstract][Full Text] [Related]
2. Microbial metabolite as icebreaker for immunotherapy.
Tang Y; Kang Y
Cell Metab; 2022 Apr; 34(4):506-507. PubMed ID: 35385701
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
5. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
6. Effects of Lean Pork on Microbiota and Microbial-Metabolite Trimethylamine-N-Oxide: A Randomized Controlled Non-Inferiority Feeding Trial Based on the Dietary Guidelines for Americans.
Dhakal S; Moazzami Z; Perry C; Dey M
Mol Nutr Food Res; 2022 May; 66(9):e2101136. PubMed ID: 35182101
[TBL] [Abstract][Full Text] [Related]
7. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
[TBL] [Abstract][Full Text] [Related]
8. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease.
Gupta N; Buffa JA; Roberts AB; Sangwan N; Skye SM; Li L; Ho KJ; Varga J; DiDonato JA; Tang WHW; Hazen SL
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1239-1255. PubMed ID: 32212854
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
10. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer.
Mirji G; Worth A; Bhat SA; El Sayed M; Kannan T; Goldman AR; Tang HY; Liu Q; Auslander N; Dang CV; Abdel-Mohsen M; Kossenkov A; Stanger BZ; Shinde RS
Sci Immunol; 2022 Sep; 7(75):eabn0704. PubMed ID: 36083892
[TBL] [Abstract][Full Text] [Related]
11. IFI35 limits antitumor immunity in triple-negative breast cancer via CCL2 secretion.
Xu B; Sun H; Liu S; Liao L; Song X; Wu Y; Hou Y; Jin W
Oncogene; 2024 Mar; 43(10):693-702. PubMed ID: 38216673
[TBL] [Abstract][Full Text] [Related]
12.
Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879
[TBL] [Abstract][Full Text] [Related]
13. Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis.
Luo Y; Zhang Y; Han X; Yuan Y; Zhou Y; Gao Y; Yu H; Zhang J; Shi Y; Duan Y; Zhao X; Yan S; Hao H; Dai C; Zhao S; Shi J; Li W; Zhang S; Xu W; Fang N; Gong Y; Li Y
EBioMedicine; 2022 Aug; 82():104087. PubMed ID: 35797768
[TBL] [Abstract][Full Text] [Related]
14. Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer.
Oellgaard J; Winther SA; Hansen TS; Rossing P; von Scholten BJ
Curr Pharm Des; 2017; 23(25):3699-3712. PubMed ID: 28641532
[TBL] [Abstract][Full Text] [Related]
15. Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction.
Chen S; Henderson A; Petriello MC; Romano KA; Gearing M; Miao J; Schell M; Sandoval-Espinola WJ; Tao J; Sha B; Graham M; Crooke R; Kleinridders A; Balskus EP; Rey FE; Morris AJ; Biddinger SB
Cell Metab; 2019 Dec; 30(6):1141-1151.e5. PubMed ID: 31543404
[TBL] [Abstract][Full Text] [Related]
16. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
[TBL] [Abstract][Full Text] [Related]
17. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
18. Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Li X; Su C; Jiang Z; Yang Y; Zhang Y; Yang M; Zhang X; Du Y; Zhang J; Wang L; Jiang J; Hong B
NPJ Biofilms Microbiomes; 2021 Apr; 7(1):36. PubMed ID: 33863898
[TBL] [Abstract][Full Text] [Related]
19. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer.
Wu SY; Xiao Y; Wei JL; Xu XE; Jin X; Hu X; Li DQ; Jiang YZ; Shao ZM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321275
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]